心臟安全服務市場規模、佔有率、成長分析（按服務、按類型、按最終用途、按地區）- 產業預測 2025-2032

預計全球心臟安全服務市場在 2023 年的價值將達到 7.4 億美元，到 2032 年將從 2024 年的 8.2436 億美元成長到 19.5523 億美元，在預測期內（2025-2032 年）的複合年成長率為 11.4%。

心血管疾病的預防，加上藥物開發活動和監管要求的增加，正在顯著推動全球心臟安全服務市場的發展。外包服務的趨勢和心電圖數據分析的進步進一步刺激了這項需求。此外，人工智慧與心臟安全監測的結合預計將推動市場成長。隨著臨床試驗的增加和對早期發現心血管風險的需求的成長，服務供應商正在擴大其提供的服務範圍，包括有助於即時心臟評估的綜合心電圖和遠端檢測服務。強調集中心臟安全資料集中並與臨床系統無縫整合，可以簡化臨床試驗、降低風險，並使外包心臟安全服務成為希望加快監管核准的製藥和生物技術公司的一個有吸引力的選擇。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術分析
• 顧客購買行為分析

心臟安全服務市場規模（依服務及複合年成長率）（2025-2032）

• 市場概覽
• 心電圖/心電圖監測
• 血壓計
• 心血管影像
• 其他

心臟安全服務市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 融合的
• 獨立

心臟安全服務市場規模（依最終用途及複合年成長率）（2025-2032 年）

• 市場概覽
• 製藥和生物製藥公司
• CRO
• 其他

心臟安全服務市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• IQVIA
• PPD Inc,
• Charles River Laboratories
• Welly sis
• Eurofins Scientific
• Celerion
• Nova Research Laboratories
• Laboratory Corporation of America Holdings
• Konin klije Philips NV
• ICON Plc.
• SGS SA
• Clario
• Viva Link
• Certara
• Richmond Pharmacology
• Biotrial

結論和建議

Global Cardiac Safety Services Market size was valued at USD 740.0 million in 2023 and is poised to grow from USD 824.36 million in 2024 to USD 1955.23 million by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The growing prevalence of cardiovascular diseases, coupled with heightened drug development activities and regulatory demands, is significantly boosting the global cardiac safety services market. The trend towards outsourcing services and advancements in ECG data analysis further enhances this demand. Additionally, the integration of artificial intelligence into cardiac safety monitoring is expected to propel market growth. As clinical trials increase and the need for early cardiovascular risk detection becomes more pressing, service providers are broadening their offerings, including comprehensive ECG and telemetry services, facilitating real-time cardiac assessments. The emphasis on centralized cardiac safety data and seamless integration with clinical systems will enhance trial efficiencies and reduce risks, making outsourcing of cardiac safety services an attractive option for pharmaceutical and biotechnology clients aiming to expedite regulatory approvals.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Safety Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Safety Services Market Segments Analysis

Global Cardiac Safety Services Market is segmented by Services, Type, End Use and region. Based on Services, the market is segmented into ECG/Holter Monitors, Blood Pressure Monitors, Cardiovascular Imaging and Others. Based on Type, the market is segmented into Integrated and Standalone. Based on End Use, the market is segmented into Pharma & Biopharma Companies, CROs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Safety Services Market

The increasing momentum in drug development, particularly within cardiovascular, oncology, and central nervous system therapies, underscores the growing necessity for cardiac safety monitoring. This heightened focus is driven by the stringent requirements imposed by regulatory bodies, necessitating comprehensive cardiac safety evaluations. As a result, there is a pronounced demand for specialized services that encompass ECG and Holter monitoring, as well as QT interval assessments. This trend reflects the industry's commitment to ensuring patient safety and the efficacy of new therapies, further reinforcing the importance of expert cardiac safety services in the drug development process.

Restraints in the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market faces significant challenges due to the substantial investment required for the implementation of advanced ECG monitoring systems, telemetry devices, and AI-driven analytics platforms. This financial burden can raise the costs associated with cardiac safety services, particularly impacting small and mid-sized pharmaceutical companies. As a result, the heightened expenses may deter these companies from investing in necessary technologies and services, ultimately hindering the overall growth potential of the market. The interplay between technological advancements and financial limitations creates a restraint that may affect market dynamics and innovation.

Market Trends of the Global Cardiac Safety Services Market

The Global Cardiac Safety Services market is experiencing a notable shift towards decentralized clinical trials, significantly enhancing the adoption of remote cardiac monitoring solutions. This trend is characterized by an increased reliance on wearable ECG devices, mobile health applications, and cloud-based telemetry platforms, allowing for the efficient capture of cardiac data beyond conventional clinical environments. As a result, participants enjoy greater convenience, and researchers can access larger and more diverse participant pools while streamlining data collection processes. This evolution not only improves the overall efficiency of cardiac safety assessments but also aligns with the growing demand for innovative digital health solutions in clinical research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis
• Customer Buying Behavior Analysis

Global Cardiac Safety Services Market Size by Services & CAGR (2025-2032)

• Market Overview
• ECG/Holter Monitors
• Blood Pressure Monitors
• Cardiovascular Imaging
• Others

Global Cardiac Safety Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Integrated
• Standalone

Global Cardiac Safety Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma & Biopharma Companies
• CROs
• Others

Global Cardiac Safety Services Market Size & CAGR (2025-2032)

• North America (Services, Type, End Use)
  • US
  • Canada
• Europe (Services, Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Services, Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Services, Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Services, Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD Inc,
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welly sis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Research Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Konin klije Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clario
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viva Link
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richmond Pharmacology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotrial
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations